Phase II study of irinotecan combined with carboplatin in previously untreated non-small-cell lung cancer

By Fukuda Minoru   Oka Mikio   Soda Hiroshi   Kinoshita Akitoshi   Fukuda Masaaki   Nagashima Seiji   Kuba Mutsuo   Takatani Hiroshi   Tsurutani Junji   Nakamura Yoichi   Kasai Takashi   Inoue Yuichi   Soejima Yoshifumi   Kohno Shigeru  

Cancer Chemotherapy and Pharmacology, Vol. 54, Iss. 6, 2004-12 ,pp. : 573-577

Springer Publishing Company

Access to resources Recommend Favorite

Comparative analysis of carboplatin and paclitaxel combination chemotherapy schedules in previously untreated patients with advanced non-small cell lung cancer

By            

Oncology Letters, Vol. 5, Iss. 3, 2013-01 ,pp. : 761-767

Spandidos Publications

Access to resources Recommend Favorite

Phase II study of concurrent thoracic radiotherapy in combination with weekly paclitaxel plus carboplatin in locally advanced non-small cell lung cancer: LOGIK0401

By Takayama Koichi   Inoue Koji   Tokunaga Shoji   Matsumoto Takemasa   Oshima Tsukasa   Kawasaki Masayuki   Imanaga Tomotoshi   Kuba Mutsuo   Takeshita Masafumi   Harada Taishi   Shioyama Yoshiyuki   Nakanishi Yoichi  

Cancer Chemotherapy and Pharmacology, Vol. 72, Iss. 6, 2013-12 ,pp. : 1353-1359

Springer Publishing Company

Access to resources Recommend Favorite

Phase II study of gemcitabine and carboplatin in patients with advanced non-small-cell lung cancer

By Wang Lin   Huang Ming   Zhang Guo   Xu Nong   Wu Xiu  

Cancer Chemotherapy and Pharmacology, Vol. 60, Iss. 4, 2007-09 ,pp. : 601-607

Springer Publishing Company

Access to resources Recommend Favorite

Phase II study of weekly docetaxel combined with cisplatin in patients with advanced non-small-cell lung cancer

By Tsunoda Toshiyuki   Koizumi Tomonobu   Hayasaka Muneharu   Hirai Kazuya   Koyama Shigeru   Takabayashi Yasuki   Fujimoto Keisaku   Kubo Keishi  

Cancer Chemotherapy and Pharmacology, Vol. 54, Iss. 2, 2004-08 ,pp. : 173-177

Springer Publishing Company

Access to resources Recommend Favorite